At Gamma Interpharm, we are committed to delivering world-class pharmaceutical products backed by science and clinical validation. We proudly conducted Bioequivalence (BE) studies for two of our key products — Glyclapan MR 60 (Gliclazide Modified Release Tablets 60 mg) and Diabx-XR (Metformin Extended Release Tablets 500 mg) — at the Kotelawala Defence University (KDU).
These studies compare our formulations with original innovator brands, ensuring that our products meet the same standards of safety, efficacy, and therapeutic performance. This is a critical step in demonstrating the high quality and clinical reliability of our medicines — made by Sri Lankans, On Sri Lankans.